Skip to content

NAD+evidence-first

The NAD Review
menu

evidence_review

How Much Does NAD+ IV Therapy Cost? (2026 Price Guide)

NAD+ IV therapy runs $250–$1,500 a session and $1,500–$6,000 a package, never covered by insurance — and the evidence rarely justifies it.

NAD+ IV therapy is one of the most aggressively upsold services in the wellness-clinic world, and the question almost nobody answers honestly is the simple one: what does it actually cost, and is the price defensible? This is a buyer's guide, not a sales page. We'll lay out the real 2026 price ranges, where the money goes, and — because cost only means something next to value — what the human evidence does and doesn't support paying for.

The short version: a single drip commonly costs a few hundred dollars, a "protocol" runs into the low thousands, none of it is covered by insurance, and the controlled human evidence that any of it improves how you feel or function is essentially absent. For most healthy people, the math doesn't work.

What a NAD+ IV drip costs in 2026

Pricing is set entirely by clinics, med-spas, and mobile-drip services — there is no list price and no insurance reimbursement, because IV NAD+ is not an FDA-approved treatment for any condition. As of 2026, the real-world ranges in the US look roughly like this:

  • A single in-clinic NAD+ infusion: about $250 to $1,000 for a standard 250–500 mg drip, with higher-dose (750–1,000 mg) or premium-location sessions reaching $1,000 to $1,500.
  • Mobile / at-home "concierge" infusions: typically $400 to $1,500+, since you're paying a nurse's travel time and a premium for convenience on top of the drip itself.
  • Multi-session packages: clinics almost always steer you toward a course — commonly 4 to 10 infusions as a "loading protocol," then ongoing "maintenance" — which puts the total at roughly $1,500 to $6,000, occasionally more.
  • Add-ons: vitamin or glutathione "cocktails," myers-style blends, membership fees, and concierge surcharges stack on top and are where a quoted "from $250" session quietly becomes a four-figure bill.

// 2026 price ranges

What NAD+ IV therapy actually costs

  • Single in-clinic infusion: ~$250–$1,500 (dose- and location-dependent)
  • Mobile / at-home concierge drip: ~$400–$1,500+ (you pay for convenience)
  • Package of 4–10 sessions: ~$1,500–$6,000 total
  • Insurance coverage: none — it is not an FDA-approved treatment
  • Add-ons (vitamin/glutathione cocktails, membership, concierge fees) stack on top
Ranges reflect typical US clinic and mobile-drip pricing as of 2026; there is no list price and no insurance reimbursement.

A few things drive the spread. Dose is the big one — a 1,000 mg drip costs the clinic more in raw compound than a 250 mg one. Setting matters (a coastal med-spa or a home visit costs more than a strip-mall IV bar). And packaging: the per-session price almost always drops when you commit to a multi-drip protocol, which is precisely the anchoring tactic that turns a "$300 try-it" into a $3,000 commitment.

Why it's never covered by insurance

This one is simple and worth stating plainly: insurance does not cover NAD+ IV therapy, full stop. Coverage requires an FDA-approved indication and evidence of medical necessity, and IV NAD+ has neither — it's marketed as a wellness or "optimization" service, which payers classify as elective. You will pay out of pocket, and HSA/FSA eligibility is not guaranteed either (it generally requires a documented medical purpose your administrator accepts). Treat any clinic that implies insurance "might" cover it with suspicion.

What you're actually paying for — and what's proven

Here's where a cost guide has to be honest, because price is meaningless without value. The marketing sells energy, mental clarity, recovery, and anti-aging. The evidence tells a much more sober story.

Start with the biology, which is real: NAD+ (nicotinamide adenine dinucleotide) is a coenzyme central to turning food into cellular energy and to DNA repair, and its availability tends to fall with age 12. That decline is the entire rationale for "restoring" NAD+. But a sound rationale is not a proven treatment.

For the IV route specifically, there is exactly one published human study that measured what an infusion does inside the body — a 2019 pilot that tracked the plasma and urine NAD+ metabolome during a 6-hour drip. It found that free NAD+ was largely undetectable in the bloodstream for hours as the body metabolized it, and — critically — it measured no health outcome at all 3. There is no randomized controlled trial showing IV NAD+ improves energy, focus, recovery, or aging. You are paying premium prices for a delivery route with zero outcome trials behind it.

What human evidence exists comes from inexpensive oral precursors (NMN and nicotinamide riboside), and even those are humbling. They reliably raise blood NAD+ in a dose-dependent way 45 — but raising the biomarker repeatedly fails to translate into felt benefit: nicotinamide riboside augmented the aged-muscle NAD+ metabolome without improving muscle performance 6, raised NAD+ ~2.6-fold without improving cognition in older adults with mild impairment 7, and a meta-analysis found benefits on metabolic-syndrome parameters limited and inconsistent despite reliably higher NAD+ 8. If the routes with actual trials struggle to convert higher NAD+ into results, an IV drip costing 50–100× more per dose cannot honestly claim to do better. We unpack the full evidence picture in our pillar guide to NAD+ therapy evidence and review the IV pitch in detail in our NAD+ IV therapy evidence review.

// Cost vs evidence

// RouteTypical 2026 costHuman evidence
IV infusion$250–$1,500/session1 PK pilot only; no outcome RCTs
Subcutaneous injectionLess per dose, still clinic-pricedNo outcome RCTs
Oral NMN / NR~$20–$40/monthRCTs show it raises NAD+ (not outcomes)
The cheapest route is the one with the most human evidence — not the most expensive. Higher blood NAD+ has not been shown to mean better outcomes.

The "maintenance" upsell and the cost-per-month trap

The single biggest driver of total spend is the maintenance schedule. Clinics commonly recommend a top-up drip every one to two weeks, and they frame it as pharmacology — "your NAD+ runs out, so you need to refill." But there is no pharmacokinetic basis for a tidy "lasts 7–14 days" figure; that interval is a scheduling and revenue convention, not a measured duration of benefit, as we explain in how long does NAD+ IV therapy last. Annualize a biweekly drip at even $400 and you're looking at $10,000+ a year for an unproven service. That recurring math, more than any single session price, is what makes IV NAD+ a poor value for most people.

Cheaper routes that have more (not less) evidence

If the appeal is "raising my NAD+," it's worth knowing that the cheapest routes are the ones with the actual human trials. Oral NMN or NR — the only forms shown in controlled studies to reliably raise blood NAD+ — cost roughly $20–$40 a month, a tiny fraction of a single IV session 45. That does not make oral precursors a proven path to energy or longevity (they aren't — see does NMN actually work). It simply means that if you insist on trying to raise NAD+, you can do it for a few dollars a day with more evidence behind the route, instead of thousands with none. We weigh the injectable claims in NAD+ injections: the evidence and the precursor comparison in NMN vs NR.

The bottom line

A NAD+ IV drip costs about $250–$1,500 per session and $1,500–$6,000 for a typical package, is never covered by insurance, and rests on a single human pharmacokinetic pilot with no outcome trials 3. The cheaper oral routes have more evidence, not less — and even they reliably raise NAD+ without reliably improving how people feel 678. For a healthy person, the honest verdict is that the cost is hard to justify. Before booking, work through the full decision framework in is NAD+ therapy worth it, read our NAD+ IV therapy evidence review and how long NAD+ IV therapy lasts, and check the products and providers on our NAD+ rankings hub.

Frequently asked questions

How much does one NAD+ IV infusion cost?

In 2026, a single in-clinic NAD+ infusion typically costs about $250 to $1,000 for a standard 250–500 mg drip, rising to $1,000–$1,500 for higher doses or premium settings. Mobile or at-home visits often run $400 to $1,500 or more because you also pay for a nurse's travel and convenience.

How much does a full NAD+ IV package cost?

Clinics usually recommend a course of 4 to 10 infusions plus ongoing maintenance drips, which puts the total at roughly $1,500 to $6,000, sometimes more. Add-ons like vitamin or glutathione cocktails, membership fees, and concierge surcharges raise the bill further.

Does insurance cover NAD+ IV therapy?

No. NAD+ IV therapy is not an FDA-approved treatment for any condition, so insurance does not cover it and you pay entirely out of pocket. HSA/FSA eligibility is not guaranteed and generally requires a documented medical purpose your administrator accepts.

Is NAD+ IV therapy worth the money?

For most healthy people, the cost is hard to justify. There are no randomized controlled trials showing IV NAD+ improves energy, focus, recovery, or aging — only a single human pharmacokinetic pilot. The cheaper oral precursor routes actually have more human evidence, costing about $20–$40 a month versus hundreds per IV session.

Is there a cheaper way to raise NAD+ than an IV?

Yes. Oral NMN or nicotinamide riboside are the only routes shown in human trials to reliably raise blood NAD+, and they cost roughly $20–$40 a month — a fraction of a single IV session. That doesn't make them a proven path to more energy or longevity, but the route has more evidence behind it than IV, not less.

References

  1. Covarrubias AJ, Perrone R, Grozio A, Verdin E (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. https://pubmed.ncbi.nlm.nih.gov/33353981/
  2. Massudi H, Grant R, Braidy N, Guest J, Farnsworth B, Guillemin GJ (2012). Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One. https://pubmed.ncbi.nlm.nih.gov/22848760/
  3. Grant R, Berg J, Mestayer R, et al. (2019). A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+. Frontiers in Aging Neuroscience. https://pubmed.ncbi.nlm.nih.gov/31572171/
  4. Yi L, Maier AB, Tao R, et al. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. https://pubmed.ncbi.nlm.nih.gov/36482258/
  5. Martens CR, Denman BA, Mazzo MR, et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. https://pubmed.ncbi.nlm.nih.gov/29599478/
  6. Elhassan YS, Kluckova K, Fletcher RS, et al. (2019). Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. Cell Reports. https://pubmed.ncbi.nlm.nih.gov/31412242/
  7. Orr ME, Kotkowski E, Ramirez P, et al. (2024). A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment. GeroScience. https://pubmed.ncbi.nlm.nih.gov/37994989/
  8. Oliveira-Cruz A, Macedo-Silva A, Silva-Lima D, et al. (2024). Effects of Supplementation with NAD+ Precursors on Metabolic Syndrome Parameters: A Systematic Review and Meta-Analysis. Hormone and Metabolic Research. https://pubmed.ncbi.nlm.nih.gov/39111741/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

continue_reading